Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic and complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. Take a look at the…
1-year chart of Apellis (APLS) below with the added notations:
APLS has formed key resistance at $70 (red) over the past two months, while also rising on top of an up-trending support line (green). These two lines have APLS trading within a common pattern known as an ascending triangle. APLS will break out of the triangle eventually, which creates an opportune trade setup.
The Tale of the Tape: APLS has formed a triangle pattern. A short trade could be made on a break of support or on a test of resistance. A long trade could be made at support or on a break through the triangle resistance of…
Continue reading at WEALTHPOP.com
